Project Grant HT94252510982
Award Date 8/15/25
Completion Date 8/14/30
Dollars Obligated $625K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Worcester, MA 01655, USA
Similar Awards
- The University of Massachusetts Medical School (UMASS Medical) was awarded a $3,854,000.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2025, will fund research targeting human respiratory viruses and host sequences using respiratory-active RNAs. UMASS Medical, a prominent academic medical center and research institution, has extensive expertise in advanced biomedical research across...
- The University of Massachusetts Medical School (UMASS Medical) was awarded a $670,000 Project Grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) with a performance period from September 1, 2025 to August 31, 2029. The grant funding will support advanced biomedical research to identify immunomodulatory targets of the TAZ/SRF pathway in the progression of sarcomatoid renal cell carcinoma. As an academic medical center and research...
- The University of Massachusetts Medical School was awarded a $749,992 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2025 to study the role of SCARF1 in efferocytosis and the prevention of lupus. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
- The University of Massachusetts (UMass) has been awarded a $413,118.75 Project Grant from the Defense Health Agency's Military Health Services Research (MHSR) Program (CFDA 12.007). The grant, which runs from September 1, 2024, to August 31, 2026, will fund research to examine the cumulative psychosocial stress and health readiness among military personnel in the Millennium Cohort Study, with a focus on understanding the role of race, ethnicity, and sex disparities. As a major land-grant...
- This federal Project Grant award of $707,438 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research to determine the molecular etiology of and strategies to block pancreatic cancer cachexia. The award was made on July 15, 2024 with a performance period ending on July 14, 2027. The prime awardee is the University of Massachusetts Medical School's Grants and Contracts Administration Division, which will conduct the research at their...
- The University of Massachusetts Medical School was awarded a $1,005,000 Project Grant from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) to develop pad inhibitors for the treatment of amyotrophic lateral sclerosis (ALS). The award, which commenced on September 30, 2024, will support research activities through September 29, 2026. The Medical School's Grants and Contracts Administration division, doing business as UMms, will lead the project...
- This $334,000 Project Grant award from the Department of Defense (DOD) Defense Health Agency supports research by The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to analyze extracellular vesicles in exhaled breath condensates for the diagnosis and monitoring of pulmonary fibrosis. The research project, funded under the DOD's Military Medical Research and Development program (CFDA 12.420), aims to develop improved diagnostic and monitoring capabilities...
- This Project Grant award of $5,712,429.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by the University of Massachusetts Medical School (UMASS Medical) to develop CRISPR-based adipose therapies for accelerated aging in irradiated nonhuman primates. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative medical solutions to critical health challenges....
- This $381,312.00 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is funding research at the University of Massachusetts Medical School to determine the molecular etiology of and strategies to block pancreatic cancer cachexia. The award has a performance period from July 15, 2024 to July 14, 2027. The University of Massachusetts Medical School is the awardee and will be conducting the research through its Grants and...
- The University of Massachusetts Amherst will receive $570,810 through January 31, 2026 from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on intracellular bacterial delivery of vaccine antigens to establish T-cell antitumor immunity in triple-negative breast cancer. The funding will support the university's applied research efforts to transform health care for service members and the public through innovative...